
Read the Journal of Managed Care + Specialty Pharmacy (JMCP) March 2025 Issue
The expanding use of continuous glucose monitoring (CGM) has been transformative in diabetes care, providing valuable real-time data and insights for diabetes management. CGM coverage in Type 2 diabetes (T2D) has increased, reaching a broader population of patients with diabetes who are recommended for CGM per clinical guidelines.
For more disease state research, view the Market Insights Program.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.